Assessment of the neovascular permeability in glioma xenografts by dynamic T1 MRI with Gadomer-17

Magnetic Resonance in Medicine

Volumn 47, Issue 2, 2002, Pages 305-313

  Verhoye, Marleen ^a,b,c   Van Der Sanden, Boudewijn P J ^a   Rijken, Paul F J W ^a,b   Peters, Hans P W ^a,b   Van Der Kogel, Albert J ^a,b   Pée, Gilke ^a   Vanhoutte, Greetje ^a,b   Heerschap, Arend ^a,b   Van Linden, Annemie Der ^a  

^a RUCA   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Dynamic T1 mapping; Gadomer 17; Hypoxic fraction; Magnetic resonance imaging; Tumor vascular permeability

Indexed keywords

CAPILLARITY; MAGNETIC RESONANCE IMAGING; MAMMALS;

COMPARTMENT MODEL; FAST DYNAMICS; GADOMER-17; HOMOGENEOUS DISTRIBUTION; HYPOXIC FRACTION; LEAKAGE VOLUMES; VASCULAR ARCHITECTURE; VASCULAR PERMEABILITY;

TUMORS;

GADOMER 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BOLUS INJECTION; COMPARTMENT MODEL; DRUG UPTAKE; GLIOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAXATION TIME; TISSUE PERFUSION; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

EID: 0036163583     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10072     Document Type: Article

References (32)

1. Cytokines in solid tumors: Interaction of tumor growth and angiogenesis
2. The role of angiogenesis in tumor growth
3. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
4. Transport of molecules across tumor vasculature
5. Leaky tumor vessels: Consequences for tumor stroma generation and for solid tumor therapy
6. Applications of magnetic resonance in model systems: Tumor biology and physiology
7. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution
8. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability
9. Tumor characterization with dynamic contrast enhanced MRI using MR contrast agents of various molecular weights
10. 1H magnetic resonance imaging of gadolinium uptake
11. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors
12. Measurements of the blood-brain-barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts
13. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents
14. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents
15. Dynamic contrast-enhanced MR imaging of bacterial abscess and VX2 carcinoma in rabbits: Comparison of gadopentetate dimeglumine and a macromolecular contrast agent
16. Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging
17. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent
18. Maximum-likelihood estimation of Rician distributed parameters
19. 1 values with snapshot-FLASH-NMR-imaging
20. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis
21. Intercapillary distance in the proliferating area of human glioma
22. In vivo 31P magnetic resonance spectroscopy and morphmetric analysis of the perfused vascular architecture of human glioma xenografts in nude mice
23. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics
24. Measurement of vascular volume fraction and blood-tissue permeability constants with pharmacokinetic model: Studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI
25. 3-Dimensional MRI quantitation of tumor vascular volume and permeability
26. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
27. Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts
28. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
29. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors